Innovation Fertility Current Investment

Value Creation

+ 250% Revenue Growth

+ 960% EBITDA Growth

Expanded from 1 to 4 clinics via both new builds and acquisitions; 7 clinics expected by the end of 2022

Upgraded systems including state-of-the art electronic medical records (“EMR”), inventory management system, call center, and billing systems

Centralized back-office operations including call center, billing, finance, and clinical compliance

Built state-of-the-art laboratories and upgraded office facilities

Hired four additional REIs, increasing IVF cycle capacity, and potential revenues by ~70%

Hired various mid-level providers to assist with new patient consultations, decreasing average appointment wait times by ~65%